- Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure. Northridge, D.B., Currie, P.F., Newby, D.E., McMurray, J.J., Ford, M., Boon, N.A., Dargie, H.J. Eur. J. Heart Fail. (1999)









